Cooley Godward Kronish
3175 Hanover Street
Palo Alto, CA 94304
02/09/2010
8:00 AM - 10:00 AM
The valuation of a medical device company for merger or acquisition is not an exact science. Some of the many variables to be taken into consideration include the company's management, market share, prospects for growth, and potential market size. Tangible and intangible assets and financial track record will be evaluated, as well as the company's reputation in the business community. The motivation and goals of key players also come into play, and current market conditions and timing are factors. A panel of industry veterans will explore the valuation process for medical device companies, discuss case studies and provide practical answers to help you increase your company's valuation.
Moderator: Frank Rahmani, Partner, Cooley Godward Kronish LLP
Panel Speakers:
- Jeffrey Gold, Venture Partner, Longitude Capital Former CEO, CryoVascular Systems
- Shahab Salemy, Director of Business Development, Medtronic CardioVascular
- Jason Yip, Principal, Montgomery & Co
To register, please click here. For more information, email Eileen Cheng or call (650) 843-5071.